Resonance Specialties Limited

Equities

RESONANCE6

INE486D01017

Specialty Chemicals

Market Closed - Bombay S.E. 06:00:55 2024-05-27 EDT 5-day change 1st Jan Change
98.9 INR -3.61% Intraday chart for Resonance Specialties Limited -5.54% -11.57%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Resonance Specialties Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Resonance Specialties Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Resonance Specialties Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Resonance Specialties Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Resonance Specialties Limited Approves Appointment of Vaibhavi Rajeshirke as Company Secretary & Compliance Officer CI
Resonance Specialties Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Resonance Specialties Limited Recommends Dividend for the Financial Year Ended March 31, 2023, Payable on or Before August 31, 2023 CI
Resonance Specialties Limited Proposes Dividend for the Financial Year 2022-23 CI
Resonance Specialties Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Resonance Specialties Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Resonance Specialties Limited Announces Demise of Minai Bhosale, Company Secretary CI
Crisil Keeps BBB- Rating on Resonance Specialties' Bank Loans; Outlook Stable MT
Resonance Specialties Limited Announces Resignation of Ashish Katariya as A Whole-Time Director CI
Resonance Specialties Limited Announces Resignation of Ashish Katariya as CEO CI
Resonance Specialties Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Resonance Specialties Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Resonance Specialties Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Resonance Specialties Limited Announces Resignation of Dwarika Agrawal as CFO CI
Resonance Specialties Limited Announces Resignation of Dwarika Agrawal as Whole-Time Director CI
Resonance Specialties Limited Recommends Dividend for the Financial Year Ended March 31, 2022 CI
Resonance Specialties Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Resonance Specialties Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Resonance Specialties Limited Declares Interim Dividend for the Financial Year 2019-20 CI
Resonance Specialties Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
Resonance Specialties Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021 CI
Chart Resonance Specialties Limited
More charts
Resonance Specialties Limited is engaged in the manufacturing and marketing of specialty chemicals. The Company is in the business of manufacturing and marketing of pyridine and pyridine derivatives, picolines and some bulk drugs. Its plant is located in the Tarapur Industrial Zone near Mumbai, India. The plant is spread across 32,000 square meters of land with class one structures. The Company has plants to manufacture pyridines, picolines, lutidines, collidines, cyanopyridines and for various value-added products. Pyridine is used in various applications, such as agrochemicals, Pharmaceuticals, latexes, food, and allied industries. Pyridine is also used in different applications such as a solvent and as a denaturant for alcohol antifreezyl mixture, ethyl alcohol and fungicides. Pyridine is also used to manufacture vitamins, medicines, food flavoring, dyes, adhesives, pesticides, and herbicides. Its nutritional products include zinc picolinate, chromium picolinate, and niacin.
More about the company
  1. Stock Market
  2. Equities
  3. RESONANCE6 Stock
  4. News Resonance Specialties Limited
  5. Crisil Keeps BBB- Rating on Resonance Specialties' Bank Loans; Outlook Stable